Final results of the prospective French CIRTACI trial are in: contrast media for diagnostic imaging are very safe in general, as long as radiologists are vigilant for patients with allergies, asthma, or previous reactions to contrast agents. The vast majority are more itchy than serious.
PET hybrid technologies are already hot, and two innovations discussed during the final session of ECR 2011 are aimed at making them more even powerful and efficient.
Five years after the first reports linking gadolinium-based MRI contrast agents to nephrogenic system fibrosis (NSF), separate presentations of post-marketing data from manufacturers and an independent prospective study supported by agencies in France have validated the low-risk status of the contrast agent Dotarem (Gd-DOTA).
Ultrasound elastography is shown to raise sensitivity by 24 percent for preoperative assessment of axillary metastases in suspected breast cancer. Meanwhile, microbubbles identify sentinel lymph nodes, minimizing operations, according to researchers presenting at ECR 2011.